- Home
- Industry Reports
- Biotechnology
- Healthcare
- Global NGS-based RNA Sequencing Market – Size, Outlook, Trends and Forecast (2023 – 2030)
NGS-based RNA sequencing is next generation sequencing a DNA technology that has revolutionized genomic research which is used to identify giga base pairs of DNA sequence within a week which has drawn huge attention from the scientific research community. Global NGS-based RNA sequencing market value is projected to be $1.05 Billion in 2017 and is expected to generate revenue of around $3.80 Billion by the end of 2024, growing at a CAGR of around 20.20% between 2017 and 2024. Increasing number of RNA-sequence grants and advantages of RNA-sequence over microarray technology are the factors enhancing the growth of the market. Standardization concerns of RNA-sequencing in diagnostic testing and storage & interpretation of sequencing data are the factors which hamper the market growth. Increasing applications of RNA-sequence in research and demand for cancer research centres are the opportunities for NGS-based RNA sequencing market.
Research Study Objectives:
- Define, estimate, and forecast the NGS-based RNA sequencing market statistics by technology, products and services, application end user and regions concerning the individual growth drivers, market trends and their contribution toward the NGS-based RNA sequencing market growth
- Provides comprehensive information regarding the key factors influencing the market growth (Drivers, Restraints & Challenges, and Opportunities)
- Estimate & forecast the market size of all the segments concerning geographies including North America, Europe, Asia Pacific, South America and the Middle East and Africa (MEA).
- Recent competitive developments including M&A (Mergers and Acquisitions), Partnerships, and Product Innovations are provided in the NGS-based RNA sequencing market analysis report.
- Analysis and conclusions on the future NGS-based RNA sequencing market outlook.
Top-down and bottom-up approaches are used to validate the NGS-based RNA sequencing market size and are used to estimate the size of other dependent submarkets. Key players in the market are identified through various secondary sources; databases including Bloomberg Businessweek, Hoovers, Factiva, journals and associations and the market revenues are estimated and are thoroughly validated through primary and secondary research. Secondary research involves the study of annual and financial reports of top players in the market, whereas primary research includes extensive interviews with the KoL’s such as CEOs, directors, board members, VP’s, sales managers, engineers, marketing executives, technicians, account managers, investors, strategic decision makers and others. The NGS-based RNA sequencing market shares and breakdowns are determined using secondary sources and are verified by the primary sources. All possible parameters/factors that are affecting the NGS-based RNA sequencing market demand are covered in the research study are verified through primary research, analysed and interpreted to get the final qualitative and quantitative data. This data is collected and added with detailed analysis from Envision Inteligence and presented in this report.
The scope of the Report
The NGS-based RNA sequencing market segmentation is as follows:
By Technology
- Nano pore sequencing
- Single-molecule real-time sequencing
- Sequencing by synthesis
- Ion semiconductor sequencing
By Application
- Expression profiling analysis
- Small RNA sequencing
- De novo transcriptome assembly
- Variant calling and transcriptome epigenetics
By End User
- Research centers and academic & government institutes
- Hospitals & clinics
- Pharmaceutical & biotechnology companies
- Other end users
Geographical Analysis:
NGS-based RNA sequencing market is segmented by geography into North America, South America, Europe, Asia Pacific and Middle East & Africa. U.S., Canada, Mexico and Costa Rica are analysed under North American region which is usually turning as the hotspot in the market. The South American region is further segregated into Brazil, Argentina, Chile, Columbia and some other emerging economies. In Europe, the market is extensively examined by covering U.K., Germany, France, Italy, Spain, Netherlands, Poland, Switzerland and some other promising economies. The Asia Pacific is further categorised by countries into China, India, Japan, South Korea, Australia & New Zealand, Malaysia, Singapore and many other emerging nations. In the Middle East & African region, Saudi Arabia, UAE, Iran, Iraq, Qatar, South Africa, Algeria, Morocco, Nigeria and so on countries are evaluated to understand the market growth lucidly.
Customization Options:
With the given research report, Envision Inteligence offers customisations as per the client’s specific requirements. The following customisation options offered for the NGS-based RNA sequencing market include:
- Scope Revision
- Geographic Analysis
- Company Profiles
- Historical Data & Forecasting
- Key Contact Persons in companies
Global NGS-based RNA sequencing Market Research Report Includes:
- An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
- To have a complete market analysis through industry value chain analysis, Porter’s Five Force Model, PESTLE, SWOT analysis, and Y-o-Y analysis.
- Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
- Identifying DROC in the current market and their impact on altering market dynamics.
- Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
- Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- Identify the latest developments, market shares and strategies that are employed by the significant NGS-based RNA sequencing market players, such as
- GATC Biotech.
- Eurofins Scientific
- PerkinElmer, Inc.
- Agilent Technologies, Inc.
- Hoffmann-La Roche AG.
- Along with these companies, many other companies are considered in the report while analysing the global NGS-based RNA sequencing competitive strategies and environment. These companies held substantial share-owning to the nature of the industry whereas, the rest of the market shares are marginal chunks to regional and local level manufacturers. Other players also have considerable presence owing to its robust brand image, geographical reach and stable customer base.
CHAPTER 1 INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2 RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1. Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3 MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter’s Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4 MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Increasing number of RNA-sequence grants
4.1.2. Rapid growth in precision medicine
4.1.3. Advantages of RNA-sequence over microarray technology
4.1.4. Technological advancements in RNA-sequence products
4.2. Market Restraints & Challenges
4.2.1. Standardization concerns of RNA-sequence in diagnostic testing
4.2.2. Storage & interpretation of sequencing data
4.3. Market Opportunities
4.3.1. Increasing applications of RNA-sequence in research
4.3.2. Demand for cancer research centres.
CHAPTER 5 GLOBAL NGS-BASED RNA SEQUENCING MARKET – BY TECHNOLOGY
5.1. Introduction
5.2. Nano pore sequencing
5.3. Single-molecule real-time sequencing
5.4. Sequencing by synthesis
5.5. Ion semiconductor sequencing
CHAPTER 6 GLOBAL NGS-BASED RNA SEQUENCING MARKET – BY PRODUCT & SERVICE
6.1. Introduction
6.1.1. Sample Preparation
6.1.1.1. Sample Preparation, By Workflow Step
6.1.1.1.1. Fragmentation, End Repair, and Size Selection
6.1.1.1.2. Library Preparation and Target Enrichment
6.1.1.1.3. Quality Control
6.1.1.2. Sample Preparation, By Method
6.1.1.2.1. Manual Sample Preparation
6.1.1.2.2. Microfluidic Sample Preparation
6.1.1.2.3. Robotic Liquid Handling Sample Preparation
6.1.2. Sequencing Platforms and Consumables
6.1.3. Sequencing Services
6.1.4. Data Analysis, Storage, and Management
CHAPTER 7 GLOBAL NGS-BASED RNA SEQUENCING MARKET – BY APPLICATION
7.1. Introduction services
7.2. Expression profiling analysis
7.3. Small RNA sequencing
7.4. De novo transcriptome assembly
7.5. Variant calling and transcriptome epigenetics
CHAPTER 8 GLOBAL NGS-BASED RNA SEQUENCING MARKET – BY END USER
8.1. Introduction
8.2. Research centers and academic & government institutes
8.3. Hospitals & Clinics
8.4. Research centers and academic & government institutes
8.5. Pharmaceutical & biotechnology companies
CHAPTER 9 GLOBAL NGS-BASED RNA SEQUENCING MARKET – BY GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.2.3. Mexico
9.2.4. Costa Rica
9.3. South America
9.3.1. Brazil
9.3.2. Argentina
9.3.3. Chile
9.3.4. Columbia
9.3.5. Others
9.4. Europe
9.4.1. U.K.
9.4.2. Germany
9.4.3. France
9.4.4. Italy
9.4.5. Spain
9.4.6. Russia
9.4.7. Netherlands
9.4.8. Switzerland
9.4.9. Poland
9.4.10. Others
9.5. Asia Pacific
9.5.1. China
9.5.2. Japan
9.5.3. India
9.5.4. South Korea
9.5.5. Australia & New Zealand
9.5.6. Malaysia
9.5.7. Singapore
9.5.8. Others
9.6. Middle East & Africa
9.6.1. UAE
9.6.2. Saudi Arabia
9.6.3. Iran
9.6.4. Iraq
9.6.5. Qatar
9.6.6. South Africa
9.6.7. Algeria
9.6.8. Morocco
9.6.9. Nigeria
9.6.10. Egypt
9.6.11. Others
CHAPTER 10 GLOBAL NGS-BASED RNA SEQUENCING MARKET – COMPANY PROFILES
10.1. Macrogen, Inc.
10.2. GATC Biotech.
10.3. Eurofins Scientific.
10.4. PerkinElmer, Inc.,
10.5. Oxford Nanopore Technologies Limited
10.6. Agilent Technologies, Inc.
10.7. F. Hoffmann-La Roche AG
10.8. QIAGEN
10.9. Pacific Biosciences of California, Inc.,
10.10. Thermo Fisher Scientific Inc.
10.11. Illumina, Inc.
10.12. Beijing Genomics Institute.
10.13. International Medical Group.
10.14. UnitedHealth Group Inc.
10.15. Allianz SE.
CHAPTER 11 GLOBAL NGS-BASED RNA SEQUENCING MARKET – COMPETITIVE LANDSCAPE
11.1. Market Share Analysis
11.2. Strategies adopted by top companies
11.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 12 MARKET INSIGHTS
12.1. Industry Experts Insights
12.2. Analysts Opinions
12.3. Investment Opportunities
CHAPTER 13 APPENDIX
13.1. List of Tables
13.2. List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Global Report
$2,700.00 – $8,100.00
- EUR: €2,482.76 - €7,448.28
- INR: ₹224,968.97 - ₹674,906.90
- AED: د.إ9,909.00 - د.إ29,727.00
- GBP: £2,136.29 - £6,408.87
Additional information
Report Type | Extensive Report, Miniature report, Snapshot Report |
---|---|
Licence | Single User License, Team License, Corporate License |
NGS-based RNA sequencing is next generation sequencing a DNA technology that has revolutionized genomic research which is used to identify giga base pairs of DNA sequence within a week which has drawn huge attention from the scientific research community. Global NGS-based RNA sequencing market value is projected to be $1.05 Billion in 2017 and is expected to generate revenue of around $3.80 Billion by the end of 2024, growing at a CAGR of around 20.20% between 2017 and 2024. Increasing number of RNA-sequence grants and advantages of RNA-sequence over microarray technology are the factors enhancing the growth of the market. Standardization concerns of RNA-sequencing in diagnostic testing and storage & interpretation of sequencing data are the factors which hamper the market growth. Increasing applications of RNA-sequence in research and demand for cancer research centres are the opportunities for NGS-based RNA sequencing market.
Research Study Objectives:
- Define, estimate, and forecast the NGS-based RNA sequencing market statistics by technology, products and services, application end user and regions concerning the individual growth drivers, market trends and their contribution toward the NGS-based RNA sequencing market growth
- Provides comprehensive information regarding the key factors influencing the market growth (Drivers, Restraints & Challenges, and Opportunities)
- Estimate & forecast the market size of all the segments concerning geographies including North America, Europe, Asia Pacific, South America and the Middle East and Africa (MEA).
- Recent competitive developments including M&A (Mergers and Acquisitions), Partnerships, and Product Innovations are provided in the NGS-based RNA sequencing market analysis report.
- Analysis and conclusions on the future NGS-based RNA sequencing market outlook.
Top-down and bottom-up approaches are used to validate the NGS-based RNA sequencing market size and are used to estimate the size of other dependent submarkets. Key players in the market are identified through various secondary sources; databases including Bloomberg Businessweek, Hoovers, Factiva, journals and associations and the market revenues are estimated and are thoroughly validated through primary and secondary research. Secondary research involves the study of annual and financial reports of top players in the market, whereas primary research includes extensive interviews with the KoL’s such as CEOs, directors, board members, VP’s, sales managers, engineers, marketing executives, technicians, account managers, investors, strategic decision makers and others. The NGS-based RNA sequencing market shares and breakdowns are determined using secondary sources and are verified by the primary sources. All possible parameters/factors that are affecting the NGS-based RNA sequencing market demand are covered in the research study are verified through primary research, analysed and interpreted to get the final qualitative and quantitative data. This data is collected and added with detailed analysis from Envision Inteligence and presented in this report.
The scope of the Report
The NGS-based RNA sequencing market segmentation is as follows:
By Technology
- Nano pore sequencing
- Single-molecule real-time sequencing
- Sequencing by synthesis
- Ion semiconductor sequencing
By Application
- Expression profiling analysis
- Small RNA sequencing
- De novo transcriptome assembly
- Variant calling and transcriptome epigenetics
By End User
- Research centers and academic & government institutes
- Hospitals & clinics
- Pharmaceutical & biotechnology companies
- Other end users
Geographical Analysis:
NGS-based RNA sequencing market is segmented by geography into North America, South America, Europe, Asia Pacific and Middle East & Africa. U.S., Canada, Mexico and Costa Rica are analysed under North American region which is usually turning as the hotspot in the market. The South American region is further segregated into Brazil, Argentina, Chile, Columbia and some other emerging economies. In Europe, the market is extensively examined by covering U.K., Germany, France, Italy, Spain, Netherlands, Poland, Switzerland and some other promising economies. The Asia Pacific is further categorised by countries into China, India, Japan, South Korea, Australia & New Zealand, Malaysia, Singapore and many other emerging nations. In the Middle East & African region, Saudi Arabia, UAE, Iran, Iraq, Qatar, South Africa, Algeria, Morocco, Nigeria and so on countries are evaluated to understand the market growth lucidly.
Customization Options:
With the given research report, Envision Inteligence offers customisations as per the client’s specific requirements. The following customisation options offered for the NGS-based RNA sequencing market include:
- Scope Revision
- Geographic Analysis
- Company Profiles
- Historical Data & Forecasting
- Key Contact Persons in companies
Global NGS-based RNA sequencing Market Research Report Includes:
- An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
- To have a complete market analysis through industry value chain analysis, Porter’s Five Force Model, PESTLE, SWOT analysis, and Y-o-Y analysis.
- Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
- Identifying DROC in the current market and their impact on altering market dynamics.
- Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
- Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- Identify the latest developments, market shares and strategies that are employed by the significant NGS-based RNA sequencing market players, such as
- GATC Biotech.
- Eurofins Scientific
- PerkinElmer, Inc.
- Agilent Technologies, Inc.
- Hoffmann-La Roche AG.
- Along with these companies, many other companies are considered in the report while analysing the global NGS-based RNA sequencing competitive strategies and environment. These companies held substantial share-owning to the nature of the industry whereas, the rest of the market shares are marginal chunks to regional and local level manufacturers. Other players also have considerable presence owing to its robust brand image, geographical reach and stable customer base.
CHAPTER 1 INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2 RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1. Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3 MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter’s Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4 MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Increasing number of RNA-sequence grants
4.1.2. Rapid growth in precision medicine
4.1.3. Advantages of RNA-sequence over microarray technology
4.1.4. Technological advancements in RNA-sequence products
4.2. Market Restraints & Challenges
4.2.1. Standardization concerns of RNA-sequence in diagnostic testing
4.2.2. Storage & interpretation of sequencing data
4.3. Market Opportunities
4.3.1. Increasing applications of RNA-sequence in research
4.3.2. Demand for cancer research centres.
CHAPTER 5 GLOBAL NGS-BASED RNA SEQUENCING MARKET – BY TECHNOLOGY
5.1. Introduction
5.2. Nano pore sequencing
5.3. Single-molecule real-time sequencing
5.4. Sequencing by synthesis
5.5. Ion semiconductor sequencing
CHAPTER 6 GLOBAL NGS-BASED RNA SEQUENCING MARKET – BY PRODUCT & SERVICE
6.1. Introduction
6.1.1. Sample Preparation
6.1.1.1. Sample Preparation, By Workflow Step
6.1.1.1.1. Fragmentation, End Repair, and Size Selection
6.1.1.1.2. Library Preparation and Target Enrichment
6.1.1.1.3. Quality Control
6.1.1.2. Sample Preparation, By Method
6.1.1.2.1. Manual Sample Preparation
6.1.1.2.2. Microfluidic Sample Preparation
6.1.1.2.3. Robotic Liquid Handling Sample Preparation
6.1.2. Sequencing Platforms and Consumables
6.1.3. Sequencing Services
6.1.4. Data Analysis, Storage, and Management
CHAPTER 7 GLOBAL NGS-BASED RNA SEQUENCING MARKET – BY APPLICATION
7.1. Introduction services
7.2. Expression profiling analysis
7.3. Small RNA sequencing
7.4. De novo transcriptome assembly
7.5. Variant calling and transcriptome epigenetics
CHAPTER 8 GLOBAL NGS-BASED RNA SEQUENCING MARKET – BY END USER
8.1. Introduction
8.2. Research centers and academic & government institutes
8.3. Hospitals & Clinics
8.4. Research centers and academic & government institutes
8.5. Pharmaceutical & biotechnology companies
CHAPTER 9 GLOBAL NGS-BASED RNA SEQUENCING MARKET – BY GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.2.3. Mexico
9.2.4. Costa Rica
9.3. South America
9.3.1. Brazil
9.3.2. Argentina
9.3.3. Chile
9.3.4. Columbia
9.3.5. Others
9.4. Europe
9.4.1. U.K.
9.4.2. Germany
9.4.3. France
9.4.4. Italy
9.4.5. Spain
9.4.6. Russia
9.4.7. Netherlands
9.4.8. Switzerland
9.4.9. Poland
9.4.10. Others
9.5. Asia Pacific
9.5.1. China
9.5.2. Japan
9.5.3. India
9.5.4. South Korea
9.5.5. Australia & New Zealand
9.5.6. Malaysia
9.5.7. Singapore
9.5.8. Others
9.6. Middle East & Africa
9.6.1. UAE
9.6.2. Saudi Arabia
9.6.3. Iran
9.6.4. Iraq
9.6.5. Qatar
9.6.6. South Africa
9.6.7. Algeria
9.6.8. Morocco
9.6.9. Nigeria
9.6.10. Egypt
9.6.11. Others
CHAPTER 10 GLOBAL NGS-BASED RNA SEQUENCING MARKET – COMPANY PROFILES
10.1. Macrogen, Inc.
10.2. GATC Biotech.
10.3. Eurofins Scientific.
10.4. PerkinElmer, Inc.,
10.5. Oxford Nanopore Technologies Limited
10.6. Agilent Technologies, Inc.
10.7. F. Hoffmann-La Roche AG
10.8. QIAGEN
10.9. Pacific Biosciences of California, Inc.,
10.10. Thermo Fisher Scientific Inc.
10.11. Illumina, Inc.
10.12. Beijing Genomics Institute.
10.13. International Medical Group.
10.14. UnitedHealth Group Inc.
10.15. Allianz SE.
CHAPTER 11 GLOBAL NGS-BASED RNA SEQUENCING MARKET – COMPETITIVE LANDSCAPE
11.1. Market Share Analysis
11.2. Strategies adopted by top companies
11.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 12 MARKET INSIGHTS
12.1. Industry Experts Insights
12.2. Analysts Opinions
12.3. Investment Opportunities
CHAPTER 13 APPENDIX
13.1. List of Tables
13.2. List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Our Clientele
Exclusive Benefits
Credibility and Transparency
We actively recruit consumers, business professionals, and hard-to-reach individuals as members of our research panels, and we build trusted, ongoing relationships with them. Thus we provide the complete list of primary and secondary data sources in the report to maintain the transparency and to assure the credibility.
Exhaustive Coverage
Detailed and extensive coverage in the geography.Survey consultation for brand tracking, concept testing, consumer behaviour, and more, we have you covered with market research services that scale to meet your needs.
Competitive Edge
Our reports cover most recent updates in the market till the date of the purchase. We identify, gather and timely deliver analysis on impact of unprecedented decisions of CXOs in COVID-19 catastrophe on many businesses, their clients and their clients' clients without additional cost.
Golden Opportunities
A comprehensive strategic sieve analysis of the market by our analysts and consultants, aided by AI tools helps us find the non-obvious, golden and emerging opportunities for you to evaluate.
Top-notch Reports Guaranteed
70% of our research is exclusive; no other research firm has the depth and breadth of our research.
Post Purchase Support
Post-purchase support is provided for all our reports, for three months from the date of purchase, where related queries will be answered within 24 business hours over telephone or email.